Nanobots Therapeutics is a biotech company focused on developing and commercializing MotionTx platform. MotionTx technology enables the development of nanobots: unique therapeutic entities that penetrate tissues with superior efficacy, enhancing drug accumulation in target cells. The company is a spin-off of ICREA and IBEC and is the result of the research led by Prof. Samuel Sánchez.
